Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor.

about

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells.Farnesyltransferase inhibitors reduce Ras activation and ameliorate acetaminophen-induced liver injury in mice.

P2860

Q42453294-29C57BBE-B7E3-4747-ABC8-35F7892164DD Q43279301-D5ED82FC-7362-4004-BE04-88E8C35E3466

P2860

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor.

Item

http://www.wikidata.org/entity/Q42041612

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@en

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@nl

type

Item

label

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@en

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@nl

prefLabel

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@en

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@nl

P1476

Inhibition of oncogene-induced ...... farnesyltransferase inhibitor.

@en

P2093

Brent R Degeorge

http://www.w3.org/2001/XMLSchema#string

James S Testa

http://www.w3.org/2001/XMLSchema#string

Jay L Rothstein

http://www.w3.org/2001/XMLSchema#string

Katharine C Degeorge

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structures of the anticancer clinical candidates R115777 (Tipifarnib) and BMS-214662 complexed with protein farnesyltransferase suggest a mechanism of FTI selectivity

Inflammation and cancer

The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins

Interleukin 24 is induced by the RET/PTC3 oncoprotein and is an autocrine growth factor for epithelial cells

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.

Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas.

P2888

1476-9255-5-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-9255-5-3

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5548816

http://www.w3.org/2001/XMLSchema#string

P6179

1045877390

http://www.w3.org/2001/XMLSchema#string

P698

18304343

http://www.w3.org/2001/XMLSchema#string

P932

2268934

http://www.w3.org/2001/XMLSchema#string

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor.

about

P2860

P2860

Inhibition of oncogene-induced inflammatory chemokines using a farnesyltransferase inhibitor.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P577

P5875

P6179

P698

P932